Fennec Pharmaceuticals GAAP EPS of $0.01 beats by $0.04, revenue of $15.11M beats by $1.27M
Source: SeekingAlpha
2026-05-14 06:39:04 ET
More on Fennec Pharmaceuticals
- Fennec Pharmaceuticals Inc. (FENC) Q4 2025 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Fennec Pharmaceuticals
- Historical earnings data for Fennec Pharmaceuticals
- Financial information for Fennec Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Fennec Pharmaceuticals GAAP EPS of $0.01 beats by $0.04, revenue of $15.11M beats by $1.27M
Fennec Pharmaceuticals Inc.
NASDAQ: FRX:CC
FRX:CC Trading
0.23% G/L:
$8.69 Last:
300 Volume:
$8.67 Open:
FRX:CC Latest News
May 21, 2026 06:01:27 pm
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
May 14, 2026 06:30:00 am
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
May 07, 2026 06:36:00 am
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
April 21, 2026 04:30:00 pm
Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
